A real world retrospective cohort study assessing the efficacy of Venetoclax Plus Azacitidine versus intensive chemotherapy as induction therapy in newly diagnosed patients with Acute Myeloid Leukemia
Latest Information Update: 09 Aug 2022
At a glance
- Drugs Azacitidine (Primary) ; Venetoclax (Primary) ; Antineoplastics
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 17 Jun 2022 Results presented at the 27th Congress of the European Haematology Association
- 24 Jan 2022 New trial record
- 14 Dec 2021 Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition